CORRESP Filing
Galmed Pharmaceuticals Ltd.
Date: Aug. 21, 2025 · CIK: 0001595353 · Accession: 0001641172-25-025014
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289703
Letter
Galmed Pharmaceuticals Ltd.
Abba Hillel Road
Ramat Gan, Israel 5250608
August 21, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, DC 20549
RE: Galmed Pharmaceuticals Ltd. (CIK 0001595353)
Registration Statement No. 333-289703 on Form F-1 (the "Registration Statement")
Ladies and Gentlemen:
Galmed Pharmaceuticals Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on August 21, 2025 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at +1 212 801 9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very
truly yours,
Galmed
Pharmaceuticals LTD.
Show Raw Text
CORRESP 1 filename1.htm Galmed Pharmaceuticals Ltd. 16 Abba Hillel Road Ramat Gan, Israel 5250608 August 21, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: Galmed Pharmaceuticals Ltd. (CIK 0001595353) Registration Statement No. 333-289703 on Form F-1 (the "Registration Statement") Ladies and Gentlemen: Galmed Pharmaceuticals Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on August 21, 2025 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at +1 212 801 9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration. Very truly yours, Galmed Pharmaceuticals LTD. By: /s/ Allen Baharaff Allen Baharaff Chief Executive Officer